Literature DB >> 17211607

Complicating infectious foci in patients with Staphylococcus aureus or Streptococcus species bacteraemia.

M L H Cuijpers1, F J Vos, C P Bleeker-Rovers, P F M Krabbe, P Pickkers, A P J van Dijk, G J A Wanten, P D Sturm, W J G Oyen, B J Kullberg.   

Abstract

Complicating infectious foci resulting from haematogenous or local spread of microorganisms are observed frequently in patients with Staphylococcus aureus bacteraemia (SAB) or Streptococcus species bacteraemia (SSB). The aim of this study was to compare the epidemiology of complicating infectious foci during SAB and SSB in a university hospital in The Netherlands. The charts of all adult patients diagnosed with SAB or SSB (except for Streptococcus pneumoniae bacteraemia) from July 2002 until December 2004 were reviewed retrospectively. Overall, 180 immunocompetent patients were identified, 127 with SAB and 53 with SSB. The percentage of patients with complicating infectious foci (39% of SAB patients, 25% of SSB patients) did not differ significantly between the groups. Endocarditis and cerebral involvement, however, were significantly more common in the SSB group. Of all complicating infectious foci, 32% lacked guiding signs or symptoms and 10% were detected only at autopsy. Factors associated with the development of complicating infectious foci were a delay in treatment for more than 48 h after the onset of symptoms, community acquisition, persistently positive blood cultures, congenital heart disease, and the presence of foreign bodies or prosthetic valves. Infection-related mortality was 18% in SAB patients and 11% in SSB patients and was significantly higher in patients with complicating infectious foci (29 vs. 9%). In conclusion, complicating infectious foci develop in approximately one-third of all patients with SAB and SSB. An active approach that entails searching for the complicating infectious foci is warranted in these patients, because only two-thirds of complicated infectious foci have guiding symptoms or signs, and infection-related mortality is significantly increased in patients with complicating infectious foci compared to patients without these infections.

Entities:  

Mesh:

Year:  2007        PMID: 17211607     DOI: 10.1007/s10096-006-0238-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  28 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

2.  18F-FDG PET in detecting metastatic infectious disease.

Authors:  Chantal P Bleeker-Rovers; Fidel J Vos; Geert J A Wanten; Jos W M van der Meer; Frans H M Corstens; Bart-Jan Kullberg; Wim J G Oyen
Journal:  J Nucl Med       Date:  2005-12       Impact factor: 10.057

3.  Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients.

Authors:  V G Fowler; J Li; G R Corey; J Boley; K A Marr; A K Gopal; L K Kong; G Gottlieb; C L Donovan; D J Sexton; T Ryan
Journal:  J Am Coll Cardiol       Date:  1997-10       Impact factor: 24.094

4.  Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients.

Authors:  V G Fowler; L K Kong; G R Corey; G S Gottlieb; R S McClelland; D J Sexton; D Gesty-Palmer; L J Harrell
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

5.  Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases.

Authors:  Allan G Jensen; Carsten H Wachmann; Frank Espersen; Jens Scheibel; Peter Skinhøj; Niels Frimodt-Møller
Journal:  Arch Intern Med       Date:  2002-01-14

Review 6.  Viridans-group streptococcal infections in immunocompromised hosts.

Authors:  J L Shenep
Journal:  Int J Antimicrob Agents       Date:  2000-03       Impact factor: 5.283

7.  Management of patients with Staphylococcus aureus bacteraemia in a university hospital: a retrospective study.

Authors:  Dominique W M Verhagen; Jan T M van der Meer; Trix Hamming; Menno D de Jong; Peter Speelman
Journal:  Scand J Infect Dis       Date:  2003

8.  Risk factors for metastatic infection in patients with Staphylococcus aureus bacteremia with and without endocarditis.

Authors:  Olivier Lesens; Yves Hansmann; Daniel Storck; Daniel Christmann
Journal:  Eur J Intern Med       Date:  2003-07       Impact factor: 4.487

9.  Staphylococcus aureus bacteremia. Current clinical patterns.

Authors:  C M Nolan; H N Beaty
Journal:  Am J Med       Date:  1976-04       Impact factor: 4.965

10.  Staphylococcus aureus endocarditis. A review of 119 cases.

Authors:  F Espersen; N Frimodt-Møller
Journal:  Arch Intern Med       Date:  1986-06
View more
  11 in total

1.  Onset of symptoms, diagnostic confirmation, and occurrence of multiple infective foci in patients with Staphylococcus aureus bloodstream infection: a look into the order of events and potential clinical implications.

Authors:  Jesper Smit; Siegbert R Rieg; Andreas F Wendel; Winfried V Kern; Harald Seifert; Henrik C Schønheyder; Achim J Kaasch
Journal:  Infection       Date:  2018-06-14       Impact factor: 3.553

2.  Septic pulmonary emboli detected by 18F-FDG PET/CT in children with S. aureus catheter-related bacteremia.

Authors:  A Méndez-Echevarria; M Coronado-Poggio; F Baquero-Artigao; T Del Rosal; S Rodado-Marina; C Calvo; L Domínguez-Gadea
Journal:  Infection       Date:  2017-02-27       Impact factor: 3.553

3.  Incidence and Risk Factors of Ocular Infection Caused by Staphylococcus aureus Bacteremia.

Authors:  Jiwon Jung; Junyeop Lee; Shi Nae Yu; Yong Kyun Kim; Ju Young Lee; Heungsup Sung; Mi-Na Kim; Sung-Han Kim; Sang-Oh Lee; Sang-Ho Choi; Jun Hee Woo; Joo Yong Lee; Yang Soo Kim; Yong Pil Chong
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

4.  Predictive factors for metastatic infection in patients with bacteremia caused by methicillin-sensitive Staphylococcus aureus.

Authors:  Tetsuya Horino; Fumiya Sato; Yumiko Hosaka; Tokio Hoshina; Kumi Tamura; Kazuhiko Nakaharai; Tetsuro Kato; Yasushi Nakazawa; Masaki Yoshida; Seiji Hori
Journal:  Am J Med Sci       Date:  2015-01       Impact factor: 2.378

5.  Plasma Cell-Free DNA Next-Generation Sequencing to Diagnose and Monitor Infections in Allogeneic Hematopoietic Stem Cell Transplant Patients.

Authors:  Monica Fung; Simona Zompi; Hon Seng; Desiree Hollemon; Adama Parham; David K Hong; Sivan Bercovici; Estelle Dolan; Kathy Lien; Justin Teraoka; Aaron C Logan; Peter Chin-Hong
Journal:  Open Forum Infect Dis       Date:  2018-11-16       Impact factor: 3.835

6.  Potential usefulness of FDG PET/CT in patients with sepsis of unknown origin.

Authors:  Jing-Ren Tseng; Ke-Yuan Chen; Ming-Hsun Lee; Ching-Tai Huang; Ying-Hao Wen; Tzu-Chen Yen
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

7.  Metastatic Spreading of Community Acquired Staphylococcus aureus Bacteraemia.

Authors:  Giovanna Fabio; Maria Carrabba; Luca Mellace; Cinzia Hu; Diego Spagnoli; Maria Domenica Cappellini
Journal:  Case Rep Infect Dis       Date:  2011-07-03

8.  A comparison of the diagnostic value of MRI and 18F-FDG-PET/CT in suspected spondylodiscitis.

Authors:  Carolijn Smids; Ilse J E Kouijzer; Fidel J Vos; Tom Sprong; Allard J F Hosman; Jacky W J de Rooy; Erik H J G Aarntzen; Lioe-Fee de Geus-Oei; Wim J G Oyen; Chantal P Bleeker-Rovers
Journal:  Infection       Date:  2016-06-17       Impact factor: 3.553

9.  Head-to-Head Comparison of 68Ga-Citrate and 18F-FDG PET/CT for Detection of Infectious Foci in Patients with Staphylococcus aureus Bacteraemia.

Authors:  Soile P Salomäki; Jukka Kemppainen; Ulla Hohenthal; Pauliina Luoto; Olli Eskola; Pirjo Nuutila; Marko Seppänen; Laura Pirilä; Jarmo Oksi; Anne Roivainen
Journal:  Contrast Media Mol Imaging       Date:  2017-10-17       Impact factor: 3.161

10.  Multimodal ophthalmic imaging of staphylococcus aureus bacteremia associated with chorioretinitis, endocarditis, and multifocal brain abscesses.

Authors:  Chiara Veronese; Marco Pellegrini; Chiara Maiolo; Mariachiara Morara; Grayson W Armstrong; Antonio P Ciardella
Journal:  Am J Ophthalmol Case Rep       Date:  2019-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.